Used in research and development for Alzheimer's disease, this antibody targets amyloid-beta peptides in the brain, helping to clear amyloid plaques associated with disease progression. It serves as a reference standard in immunoassays, ELISA, and immunohistochemistry to evaluate amyloid burden in preclinical studies. Commonly used in quality control for diagnostic kits and therapeutic antibody development. Supports consistency and accuracy in studies measuring anti-amyloid immune responses.